Left ventricular assist device

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

A left ventricular assist device or LVAD is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for bridge to transplant (BTT) or destination therapy (DT). Currently, the top three companies in this field are:

  1. Thoratec - Heartmate2 market capital $2B US
  2. Ventracor - VentrAssist
  3. Heartware